Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Venrock Healthcare Capital Partners II, L.P. GHRS GH Research PLC 13G/A 2.5% 2y
Patria Finance Limited LVROF Lavoro Ltd 13G 84.8% 2y
ArrowMark Colorado Holdings LLC BANX ArrowMark Financial Corp. 13G/A 6.27% 2y
First Trust Capital Management L.P. GDST Chi Special Acquisition Corp. 13G 5.64% 2y
Venrock Healthcare Capital Partners III, L.P. AVTX Avalo Therapeutics, Inc. 13G/A 0% 2y
Aristotle Capital Management, LLC MLM Martin Marietta Materials Inc 13G/A 4.81% 2y
MOORE CAPITAL MANAGEMENT, LP ADER 26 Capital Acquisition Corp. Class A Common Stock 13G/A 0% 2y
Select Equity Group, L.P. CDW CDW Corp 13G/A 3.9% 2y
Qiming U.S. Healthcare Fund II, L.P. JSPR Jasper Therapeutics, Inc. 13G/A 6.2% 2y
Andrew Y. Ng COUR Coursera, Inc. 13G/A 4.8% 2y
Thomas F. Frist, Jr. HCA HCA Healthcare, Inc. 13G/A 25.9% 2y
Point72 Asset Management, L.P. CRBU Caribou Biosciences, Inc. 13G/A 4.5% 2y
12 West Capital Management LP CXM Sprinklr, Inc. 13G/A 0% 2y
TCI FUND MANAGEMENT LTD CP Canadian Pacific Kansas City Ltd 13G/A 5.96% 2y
Walleye Capital LLC DUET DUET Acquisition Corp. Class A Common Stock 13G 9.36% 2y
ALLIANCEBERNSTEIN L.P. NOMD Nomad Foods Ltd 13G/A 4.2% 2y
Avidity Partners Management LP KZR Kezar Life Sciences, Inc. 13G/A 6.9% 2y
PRICE T ROWE ASSOCIATES INC /MD/ IP International Paper Co 13G/A 4.5% 2y
Vellar Opportunities Fund Master, Ltd. SATX SatixFy Communications Ltd. 13G/A 0% 2y
Madison Avenue Partners, LP GIII G III Apparel Group Ltd 13G/A 2.9% 2y
T. Rowe Price Investment Management, Inc. UTZ Utz Brands, Inc. 13G 5.1% 2y
GLAZER CAPITAL, LLC ATMC AlphaTime Acquisition Corp Ordinary Shares 13G 6.87% 2y
Fourthstone LLC ALPIB Alpine Banks Of Colorado 13G/A 5.92% 2y
AMERIPRISE FINANCIAL INC LOB Live Oak Bancshares, Inc. 13G/A 1.99% 2y
PRICE T ROWE ASSOCIATES INC /MD/ NOW ServiceNow, Inc. 13G/A 4.1% 2y
Radcliffe Capital Management, L.P. JGGC Jaguar Global Growth Corporation I Class A Ordinary Shares 13G/A 0% 2y
AY2 Capital LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13G 8.1% 2y
Fourthstone LLC RVSB Riverview Bancorp Inc 13G 8.16% 2y
PRICE T ROWE ASSOCIATES INC /MD/ ZBH Zimmer Biomet Holdings, Inc. 13G 4.5% 2y
Water by Nordic AB BYNO byNordic Acquisition Corp 13G 52.36% 2y
T. Rowe Price Investment Management, Inc. VLTO Veralto Corp 13G 7.6% 2y
ROTHBLATT MARTINE A UTHR UNITED THERAPEUTICS Corp 13G/A 7.8% 2y
Mark Locke GENI Genius Sports Ltd 13G/A 9.8% 2y
ARMISTICE CAPITAL, LLC NVRO NEVRO CORP. 13G 8.76% 2y
Ionic Capital Management LLC JTAI Jet.AI Inc. 13G 5.4% 2y
Telegraph Hill Partners IV, L.P. TKNO Alpha Teknova, Inc. 13G/A 62.9% 2y
Ayrton Capital LLC ATXG Addentax Group Corp. 13G 9.9% 2y
CITADEL ADVISORS LLC FRBN Forbion European Acquisition Corp. Class A Ordinary Shares 13G/A 0% 2y
Richard Scanlon TBLA Taboola.com Ltd. 13G/A 1.2% 2y
Flat Footed LLC SMHI SEACOR Marine Holdings Inc. 13G/A 4.1% 2y
Forbion Capital Fund III Cooperatief U.A. ENGN enGene Therapeutics Inc. 13G/A 14.2% 2y
First Trust Capital Management L.P. TWOA two 13G 5.23% 2y
Point72 Asset Management, L.P. FTCH Farfetch Limited Class A Ordinary Shares 13G/A 5.8% 2y
Alan J. Hyatt SHBI Shore Bancshares Inc 13G/A 5.3% 2y
Cormorant Asset Management, LP PRAX Praxis Precision Medicines, Inc. 13G/A 7.39% 2y
Granahan Investment Management, LLC PRCH Porch Group, Inc. 13G/A 12.03% 2y
NOMURA HOLDINGS INC BOAC Bluescape Opportunities Acquisition Corp. 13G/A 0% 2y
ARMISTICE CAPITAL, LLC PRFX PRF Technologies Ltd. 13G 9.99% 2y
PAULSON & CO. INC. NG Novagold Resources Inc 13G/A 7% 2y
Christopher Vanderhook DSP Viant Technology Inc. 13G 34.2% 2y